0000950170-24-057822.txt : 20240510 0000950170-24-057822.hdr.sgml : 20240510 20240510161136 ACCESSION NUMBER: 0000950170-24-057822 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240506 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Andrea Carrie CENTRAL INDEX KEY: 0001977969 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 24934962 MAIL ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-649-9272 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4/A 1 ownership.xml 4/A X0508 4/A 2024-05-06 2024-05-08 0001444192 Acasti Pharma Inc. ACST 0001977969 D'Andrea Carrie 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 false true false false VP Clinical Operations false Stock Options (Right to Buy) 2.96 2024-05-06 4 A false 19740 0 A 2034-05-06 Class A Common Shares 19740 19740 D This amendment to Form 4 is being filed to amend the signature block in the original Form 4, filed on May 8, 2024, to reflect the correct signatory. Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period. /s/ Carrie D'Andrea 2024-05-10